Taysha Gene Therapies, Inc. (TSHA): Nasdaq/NYSE listing notice — Taysha Gene Therapies receives Nasdaq notice for non-compliance with MVLS minimum $50M

Taysha Gene Therapies, Inc.

Received written notice from Nasdaq on Aug 3, 2023 for failing to meet $50M minimum MVLS requirement.
Has until Jan 30, 2024 to regain compliance by closing at $50M+ for 10 consecutive business days.
Common stock continues trading on Nasdaq Global Select under TSHA; may consider transfer to Cap Market.
Company intends to monitor MVLS and explore available options; no immediate delisting.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Taysha Gene Therapies, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: market value
Rules: 5450(b)(2)(A)

Exact text from the filing

August 3, 2023, Taysha Gene Therapies, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock (the “Common Stock”), which continues to trade on The Nasdaq Global Select Market under the symbol “T

View on SEC.gov

Browse all listing & compliance notices →

Taysha Gene Therapies, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-203836

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.